Factors associated with dengue fatality in Fiji: a hospital-based case control study Dengue fatality in Fiji

Main Article Content

Aneley Getahun
Anaseini Batikawai
Sabiha Khan
Devina Nand
Devina Nand
Ravi Naidu
Renata Ram
Shivnay Naidu

Keywords

Abstract

Introduction: Fiji experienced a dengue serotype 3 outbreak in 2013-14 with a higher number of fatalities compared to an earlier outbreak of similar intensity. This study was conducted to determine the factors associated with dengue mortality during the 2014 outbreak.


Methods: A matched case control study was conducted. Cases were patients who died of dengue (n=30) and controls were patients with laboratory confirmed dengue who were hospitalized and survived (n=90). A standardized data collection form was used to extract information from medical folders.


Findings: In this study predictors of dengue death included, haemorrhagic manifestations (odds ratio(OR) 2.63, 95% confidence interval (CI) 1.09,6.36), abdominal tenderness (OR 4.32, 95%CI 1.10,17.03), leucocytosis (OR 2.92, 95%CI 1.29,29.74) and serum creatinine > 150mg/dl (OR 6.19, 95%CI 1.29,29.74) at admission and development of shock (OR 40.05, 95%CI 5.26,305.19) during hospital stay. Living in urban location was also associated with dengue fatality (OR 5.78, 95%CI 1.57,21.22).


Conclusion: Findings of this study should be used by clinicians for prompt identification and appropriate treatment of dengue as well as for public health measures to reduce dengue related mortality in Fiji.

Abstract 543 | PDF Downloads 106

References

1. Bhatt, S.; Gething, P. W.; Brady, O. J.; Messina, J. P.; Farlow, A. W.; Moyes, C. L.; Drake, J. M.; Brownstein, J. S.; Hoen, A. G.; Sankoh, O.; Myers, M. F.; George, D. B.; Jaenisch, T.; Wint, G. R.; Simmons, C. P.; Scott, T. W.; Farrar, J. J.; Hay, S. The global distribution and burden of dengue. Nature 2013, 496 (7446), 504-7.
2. WHO, Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization 2009. http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf.
3. Cao-Lormeau, V. M.; Roche, C.; Musso, D.; Mallet, H. P.; Dalipanda, T.; Dofai, A.; Nogareda, F.; Nilles, E. J.; Aaskov, J., Dengue virus type 3, South Pacific Islands, 2013. Emerg Infect Dis 2014, 20 (6), 1034-6.
4. Roth, A.; Mercier, A.; Lepers, C.; Hoy, D.; Duituturaga, S.; Benyon, E.; Guillaumot, L.; Souares, Y., Concurrent outbreaks of dengue, chikungunya and Zika virus infections - an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014. Euro Surveill 2014, 19 (41).
5. Singh, N.; Kiedrzynski, T.; Lepers, C.; Benyon, E. K., Dengue in the Pacific--an update of the current situation. Pac Health Dialog 2005, 12 (2), 111-9.
6. FIBOS, Census of Population and Housing, 3007 Suva. Fiji Islands Bureau of Statistics 2007. 2007.
7. MOHMS Annual report, 2014 http://www.health.gov.fj/PDFs/Annual%20Report/Annual%20Report%202014.pdf
8. Reed, D.; Maguire, T.; Mataika, J., Type 1 dengue with hemorrhagic disease in Fiji: epidemiologic findings. Am J Trop Med Hyg 1977, 26 (4), 784-91.
9. Fagbami, A. H.; Mataika, J. U.; Shrestha, M.; Gubler, D. J., Dengue type 1 epidemic with haemorrhagic manifestations in Fiji, 1989-90. Bull World Health Organ 1995, 73 (3), 291-7.
10. Prakash G, R. A., Koroivueta J DF/DHF and its control in Fiji. Dengue Bulletin 2001, 21, 21-27.
11. WHO, Dengue haemorrhagic fever Diagnosis, treatment, prevention and control. . 2nd edition ed.; Geneva:World Health Organization 1997. http://apps.who.int/iris/bitstream/10665/41988/1/9241545003_eng.pdf.
12. CDC Dengue Case Management. https://www.cdc.gov/dengue/resources/dengue-clinician-guide_508.pdf.
13. Pinto, R. C.; Castro, D. B.; Albuquerque, B. C.; Sampaio Vde, S.; Passos, R. A.; Costa, C. F.; Sadahiro, M.; Braga, J. U., Mortality Predictors in Patients with Severe Dengue in the State of Amazonas, Brazil. PLoS One 2016, 11 (8), e0161884.
14. Thanachartwet, V., Oer-Areemitr, N., Chamnanchanunt, S., Sahassananda, D., Jittmittraphap, A., Suwannakudt, P & Wattanathum, A, Identification of clinical factors associated with severe dengue among Thai adults: a prospective study. BMC infectious diseases 2015, 15 (1), 1.
15. Moraes, G. H.; de Fatima Duarte, E.; Duarte, E. C., Determinants of mortality from severe dengue in Brazil: a population-based case-control study. Am J Trop Med Hyg 2013, 88 (4), 670-6.
16. Diaz-Quijano, F. A.; Waldman, E. A., Factors associated with dengue mortality in Latin America and the Caribbean, 1995-2009: an ecological study. Am J Trop Med Hyg 2012, 86 (2), 328-34.
17. Almas, A.; Parkash, O.; Akhter, J., Clinical factors associated with mortality in dengue infection at a tertiary care center. Southeast Asian J Trop Med Public Health 2010, 41 (2), 333-40.
18. WHO, International Statistical Classification of Diseases and Related Health Problems. 10th revision (ICD-10). Geneva:World Health Organization., 2010. http://apps.who.int/classifications/icd10/browse/2016/en.
19. FIBOS, 2007 Fiji Census of Population and Housing –Analytical Report. Suva Fiji, 2012.
20. Liew, S. M.; Khoo, E. M.; Ho, B. K.; Lee, Y. K.; Omar, M.; Ayadurai, V.; Mohamed Yusoff, F.; Suli, Z.; Mudin, R. N.; Goh, P. P.; Chinna, K., Dengue in Malaysia: Factors Associated with Dengue Mortality from a National Registry. PLoS One 2016, 11 (6), e0157631.
21. Mallhi, T. H.; Khan, A. H.; Adnan, A. S.; Sarriff, A.; Khan, Y. H.; Jummaat, F., Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study. BMC Infect Dis 2015, 15, 399.
22. Mallhi, T. H.; Khan, A. H.; Sarriff, A.; Adnan, A. S.; Khan, Y. H., Determinants of mortality and prolonged hospital stay among dengue patients attending tertiary care hospital: a cross-sectional retrospective analysis. BMJ Open 2017, 7 (7), e016805.
23. Hanafusa, S.; Chanyasanha, C.; Sujirarat, D.; Khuankhunsathid, I.; Yaguchi, A.; Suzuki, T., Clinical features and differences between child and adult dengue infections in Rayong Province, southeast Thailand. Southeast Asian J Trop Med Public Health 2008, 39 (2), 252-9.
24. WHO, Handbook for clinical management of dengue. Geneva: World Health Organization, 2012. http://www.wpro.who.int/mvp/documents/handbook_for_clinical_management_of_dengue.pdf.
25. Lahiri, M.; Fisher, D.; Tambyah, P. A., Dengue mortality: reassessing the risks in transition countries. Trans R Soc Trop Med Hyg 2008, 102 (10), 1011-6.
26. La Russa VF, I. B., Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clinical Haematology 1995, 8, 249–270.
27. MOHMS Fiji Non-Communicable diseases (NCD) steps survey. ; Suva: Fiji Ministry of Health and Medical Services 2011.
28. Paixão Enny Santos, C. M. d. C. N., Rodrigues Laura Cunha, Rasella Davide, Cardim Luciana Lobato, Brasileiro Alcione Cunha et al . Trends and factors associated with dengue mortality and fatality in Brazil. Rev. Soc. Bras. Med. Trop 2015, 48 (4), 399-405.